Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/76903
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Watts, R. | - |
dc.contributor.author | London, J. | - |
dc.contributor.author | van Wijk, R. | - |
dc.contributor.author | Lui, Y. | - |
dc.date.issued | 2012 | - |
dc.identifier.citation | Anaesthesia and Intensive Care, 2012; 40(2):333-339 | - |
dc.identifier.issn | 0310-057X | - |
dc.identifier.issn | 1448-0271 | - |
dc.identifier.uri | http://hdl.handle.net/2440/76903 | - |
dc.description.abstract | This retrospective casenote audit involving 374 patients requiring intubation for an anaesthetic found that when the availability of sugammadex became unrestricted, its use increased from 7.1 to 65.3% (P <0.0001) of all muscle relaxant reversals, while neostigmine use decreased from 59.6 to 12.5%. Rocuronium use decreased slightly (90.8 to 79.2%, P=0.006) but vecuronium use increased (2.1 to 8.3%, P=0.02). Cisatracurium and suxamethonium use were unchanged. Total rocuronium dose (55.9 ± 24.1 vs 60.4 ± 22.3 mg) and the number of doses (1.9 ± 1.48 to 1.96 ± 1.27) were unchanged, but the time between the last dose and reversal decreased (91.7 ± 68.1 to 62 ± 52.4 minutes, P=0.0002). There appeared to be no change in postoperative nausea and vomiting, or post-anaesthesia care unit time or oxygen saturation levels. Anaesthetic theatre time fell from 143.5 ± 85.8 to 120 ± 71.2 minutes (P=0.01) and remained significant when adjusted for confounding variables (ratio of means 1.17, 95% confidence interval 1.03 to 1.34, P=0.02), although inferences in relation to causality are limited by the retrospective and observational design of the study. Hospital stay also appeared to fall (4.2 ± 3.5 to 3.4 ± 3.0 days, P=0.035), but was not statistically significant when adjusted for confounding variables (ratio of means 1.04, 95% confidence interval 0.89 to 1.2, P=0.59). These observations suggest that the unrestricted availability of sugammadex will change how steroid-based neuromuscular blocking drugs are used and reversed, but further research is needed to determine if patient outcomes will improve. | - |
dc.description.statementofresponsibility | R. W. Watts, J. A. London, R. M. A. W. Van Wijk, Y.-L. Lui | - |
dc.language.iso | en | - |
dc.publisher | Australian Soc Anaesthetists | - |
dc.rights | Copyright 2012 Australian Society of Anaesthetists | - |
dc.source.uri | http://go.galegroup.com.proxy.library.adelaide.edu.au/ps/i.do?id=GALE%7CA286719404&v=2.1&u=adelaide&it=r&p=AONE&sw=w | - |
dc.subject | sugammadex | - |
dc.subject | unrestricted use | - |
dc.subject | rocuronium use | - |
dc.subject | theatre time | - |
dc.subject | hospital stay | - |
dc.title | The influence of unrestricted use of sugammadex on clinical anaesthetic practice in a tertiary teaching hospital | - |
dc.type | Journal article | - |
dc.identifier.doi | 10.1177/0310057x1204000218 | - |
pubs.publication-status | Published | - |
dc.identifier.orcid | van Wijk, R. [0000-0001-8498-9861] | - |
Appears in Collections: | Anaesthesia and Intensive Care publications Aurora harvest |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.